Tag breast [more than 800 articles] Export

Recent papers classified by the tag breast.

	Variation in the FGFR2 Gene and the Effects of Postmenopausal Hormone Therapy on Invasive Breast Cancer. [My Copy] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (27 October 2009) by Ross L. Prentice, Ying Huang, David A. Hinds, et al.Ulrike Peters, Mary Pettinger, David R. Cox, Erica Beilharz, Rowan T. Chlebowski, Jacques E. Rossouw, Bette Caan, Dennis G. Ballinger posted to polymorphism fgfr2 cancer breast by songpku on 2009-11-07 17:59:33 as
	An Admixture Scan in 1,484 African American Women with Breast Cancer. [My Copy] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (20 October 2009) by Laura Fejerman, Christopher A. Haiman, David Reich, et al.Arti Tandon, Rahul C. Deo, Esther M. John, Sue A. Ingles, Christine B. Ambrosone, Dana Howard H. Bovbjerg, Lina H. Jandorf, Warren Davis, Gregory Ciupak, Alice S. Whittemore, Michael F. Press, Giske Ursin, Leslie Bernstein, Scott Huntsman, Brian E. Henderson, Elad Ziv, Matthew L. Freedman posted to racial genetic disparity cancer breast american african admixture by songpku on 2009-11-07 17:38:24 as
	Formation of tissue factor-factor VIIa-factor Xa complex prevents apoptosis in human breast cancer cells. [My Copy] Thrombosis and haemostasis, Vol. 96, No. 2. (August 2006), pp. 196-201. by Xiaofeng Jiang, Yan Lin L. Guo, Michael E. Bromberg posted to tissuefactor factorvii cancer breast apoptosis by bmduggan on 2009-11-05 18:26:01 as
	Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells. [My Copy] Journal of Thrombosis and Haemostasis, Vol. 5, No. 8. (August 2007), pp. 1588-1597. by T. Albrektsen, B. B. Sørensen, G. M. Hjortø, J. Fleckner, L. V. Rao, L. C. Petersen posted to tissuefactor factorvii cancer breast by bmduggan on 2009-11-05 18:23:39 as
	Germ line polymorphism in metastatic progression. [My Copy] Cancer research, Vol. 66, No. 3. (1 February 2006), pp. 1251-1254. by Kent W. Hunter, Nigel P. Crawford posted to review polymorphism metastasis germline cancer breast by songpku on 2009-11-05 16:35:35 as
	Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis. [My Copy] International journal of cancer. Journal international du cancer, Vol. 124, No. 7. (1 April 2009), pp. 1716-1720. by Mia M. Gaudet, Kent Hunter, Paul Pharoah, et al.Alison M. Dunning, Kristy Driver, Jolanta Lissowska, Mark Sherman, Beata Peplonska, Louise A. Brinton, Stephen Chanock, Montserrat Garcia-Closas posted to sipa polymorphis cancer breast by songpku on 2009-11-05 16:35:24 as along with 2 people and 1 group leliavski Zephyrus Breast Cancer Reading Club
	Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer. [My Copy] Breast cancer research : BCR, Vol. 8, No. 2. (2006) by Nigel P. Crawford, Argyrios Ziogas, David J. Peel, James Hess, Hoda Anton-Culver, Kent W. Hunter posted to sipa polymorphism metastasis germline cancer breast by songpku on 2009-11-05 16:34:07 as
	Host genetics influence tumour metastasis. [My Copy] Nature reviews. Cancer, Vol. 6, No. 2. (February 2006), pp. 141-146. by Kent Hunter posted to polymorphis metastasis germline genetic cancer breast by songpku on 2009-11-05 16:33:01 as along with 1 person misonneh
	Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study. [My Copy] Breast cancer research : BCR, Vol. 11, No. 5. (13 October 2009), R75. by Szu-Min M. Hsieh, Maxime P. Look, Anieta M. Sieuwerts, John A. Foekens, Kent W. Hunter posted to snp sipa polymorphism metastasis cancer breast by songpku on 2009-11-05 16:25:48 as along with 1 person merpublic
	The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis [My Copy] Nat Cell Biol, Vol. 10, No. 2. (13 January 2008), pp. 202-210. by Qihong Huang, Kiranmai Gumireddy, Mariette Schrier, et al.Carlos le Sage, Remco Nagel, Suresh Nair, David A. Egan, Anping Li, Guanghua Huang, Andres J. Klein-Szanto, Phyllis A. Gimotty, Dionyssios Katsaros, George Coukos, Lin Zhang, Ellen Pure, Reuven Agami posted to mirna micrna metastasis cancer breast by songpku on 2009-11-05 16:17:58 as along with 2 people valeriehilgers lp2
	KLF17 is a negative regulator of epithelial\|[ndash]\|mesenchymal transition and metastasis in breast cancer [My Copy] Nat Cell Biol, Vol. 11, No. 11. (04 October 2009), pp. 1297-1304. by Kiranmai Gumireddy, Anping Li, Phyllis A. Gimotty, et al.Andres J. Klein-Szanto, Louise C. Showe, Dionyssios Katsaros, George Coukos, Lin Zhang, Qihong Huang posted to metastasis klf17 cancer breast by songpku on 2009-11-05 16:11:27 as
	Lactation and Incidence of Premenopausal Breast Cancer: A Longitudinal Study [My Copy] Arch Intern Med, Vol. 169, No. 15. (10 August 2009), pp. 1364-1371. by Alison M. Stuebe, Walter C. Willett, Fei Xue, Karin B. Michels posted to premenopausal lactation feeding cancer breast by songpku on 2009-11-05 15:50:08 as along with 1 person ggrassi
	Socioeconomic disparities in breast cancer survival: relation to stage at diagnosis, treatment and race [My Copy] BMC Cancer, Vol. 9, No. 1. (14 October 2009), 364. by Xue Yu posted to status socioeconomic ses racial disparity cancer breast by songpku on 2009-11-05 14:27:42 as
	Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. [My Copy] PloS one, Vol. 3, No. 7. (2008) by Martin Widschwendter, Sophia Apostolidou, Elke Raum, et al.Dietrich Rothenbacher, Heidi Fiegl, Usha Menon, Christa Stegmaier, Ian J. Jacobs, Hermann Brenner posted to polycomb peripheral_blood methylation hr gene_specific_methylation epigenetics breast association by misonneh on 2009-11-04 21:44:12 as
	Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, No. 11. (1 June 2008), pp. 3494-3502. by Heidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger, et al.Georg Hutarew, Roland Reitsamer, Robin L. Jones, Mitch Dowsett, Elisabeth Mueller-Holzner, Gudrun Windbichler, Günter Daxenbichler, Georg Goebel, Christian Ensinger, Ian Jacobs, Martin Widschwendter posted to response prediction pharmacogenetics neurod1 neoadjuvant methylation gene_specific_methylation epigenetics circ_dna chemotherapy breast by misonneh on 2009-11-04 21:21:37 as
	Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. [My Copy] Human mutation, Vol. 30, No. 1. (January 2009), pp. 79-84. by Zhibin Hu, Jie Liang, Zhanwei Wang, et al.Tian Tian, Xiaoyi Zhou, Jiaping Chen, Ruifen Miao, Yan Wang, Xinru Wang, Hongbing Shen posted to variant pre-microrna polymorphism mirna genetic cancer breast by songpku on 2009-11-03 20:06:27 as along with 1 person daforerog
	tRNA over-expression in breast cancer and functional consequences. [My Copy] Nucleic acids research (25 September 2009) by Mariana Pavon-Eternod, Suzanna Gomes, Renaud Geslain, Qing Dai, Marsha Rich R. Rosner, Tao Pan posted to usage trna concentration codon cancer breast by saunders on 2009-11-03 14:23:17 as
	Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors. [My Copy] British journal of cancer, Vol. 101, No. 8. (20 October 2009), pp. 1253-1260. by M. Hauglid Flågeng, Haugan L. Moi, J. M. Dixon, et al.J. Geisler, E. A. Lien, W. R. Miller, P. E. Lønning, G. Mellgren posted to response prediction nuclear_receptor neoadjuvant kim_ her2 expression breast aromatase_inhibitor by misonneh on 2009-11-03 06:03:37 as
	Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution [My Copy] Nature, Vol. 461, No. 7265. (08 October 2009), pp. 809-813. by Sohrab P. Shah, Ryan D. Morin, Jaswinder Khattra, et al.Leah Prentice, Trevor Pugh, Angela Burleigh, Allen Delaney, Karen Gelmon, Ryan Guliany, Janine Senz, Christian Steidl, Robert A. Holt, Steven Jones, Mark Sun, Gillian Leung, Richard Moore, Tesa Severson, Greg A. Taylor, Andrew E. Teschendorff, Kane Tse, Gulisa Turashvili, Richard Varhol, Rene L. Warren, Peter Watson, Yongjun Zhao, Carlos Caldas, David Huntsman, Martin Hirst, Marco A. Marra, Samuel Aparicio posted to snp sequencing cancer breast by chvlyl on 2009-11-02 06:55:07 as along with 11 people and 2 groups jwfoley stubrown giovenko frohike brianb Zephyrus jsuchit mkiyer torfinnnome merpublic djkt Chinnaiyan Lab Journal picks
	Gene-Expression Signatures in Breast Cancer [My Copy] N Engl J Med, Vol. 360, No. 8. (19 February 2009), pp. 790-800. by Christos Sotiriou, Lajos Pusztai posted to signature review gene expression cancer breast by songpku on 2009-11-01 20:31:42 as along with 6 people and 1 group giovenko tonamswish jfr Zephyrus edwardli misonneh Breast Cancer Reading Club
	MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype [My Copy] Genome Biology, Vol. 8, No. 10. (08 October 2007), R214. by Cherie Blenkiron, Leonard Goldstein, Natalie Thorne, et al.Inmaculada Spiteri, Suet F. Chin, Mark Dunning, Nuno B. Morais, Andrew Teschendorff, Andrew Green, Ian Ellis, Simon Tavare, Carlos Caldas, Eric Miska posted to tumor subtype microrna expression cancer breast by songpku on 2009-11-01 20:24:21 as along with 7 people and 2 groups Zephyrus rdiaz Stew jfr heliopais ealloza giovenko Bioinformatics - CRUK microRNA
	MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer. [My Copy] Cancer treatment reviews, Vol. 35, No. 4. (June 2009), pp. 328-334. by Ming Shi, Ning Guo posted to prognosis microrna expression diagnosis cancer breast by songpku on 2009-11-01 20:21:40 as
	MicroRNA gene expression deregulation in human breast cancer. [My Copy] Cancer research, Vol. 65, No. 16. (15 August 2005), pp. 7065-7070. by Marilena V. Iorio, Manuela Ferracin, Chang-Gong G. Liu, et al.Angelo Veronese, Riccardo Spizzo, Silvia Sabbioni, Eros Magri, Massimo Pedriali, Muller Fabbri, Manuela Campiglio, Sylvie Ménard, Juan P. Palazzo, Anne Rosenberg, Piero Musiani, Stefano Volinia, Italo Nenci, George A. Calin, Patrizia Querzoli, Massimo Negrini, Carlo M. Croce posted to mirna microrna expression cancer breast by songpku on 2009-11-01 20:17:23 as along with 5 people and 1 group tonamswish frohike eckart_bindewald ealloza robertlsons BioinfoCIPF
	Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down. [My Copy] BMC genomics, Vol. 10, No. 1. (28 October 2009), 499. by Jose L. Costa, Paul P. Eijk, Mark A. van de Wiel, et al.Derk Ten Berg, Fernando Schmitt, Carmen J. Narvaez, Joellen Welsh, Bauke Ylstra posted to vitamin mcf-7 d cancer breast by songpku on 2009-11-01 16:49:47 as
	microRNA miR-196a-2 and Breast Cancer: A Genetic and Epigenetic Association Study and Functional Analysis [My Copy] Cancer Res, Vol. 69, No. 14. (15 July 2009), pp. 5970-5977. by Aaron E. Hoffman, Tongzhang Zheng, Chunhui Yi, et al.Derek Leaderer, Joanne Weidhaas, Frank Slack, Yawei Zhang, Trupti Paranjape, Yong Zhu posted to microrna epigenetic cancer breast by songpku on 2009-10-29 19:46:42 as along with 1 person and 1 group misonneh MGEL Reading
	The effect of genetic variability on drug response in conventional breast cancer treatment. [My Copy] European journal of pharmacology (18 October 2009) by Emilia Wiechec, Lise Lotte L. Hansen posted to review response pharmacogenetics metabolism genetics chemotherapy breast by misonneh on 2009-10-29 07:12:29 as
	Relationship Between Potentially Modifiable Lifestyle Factors and Risk of Second Primary Contralateral Breast Cancer Among Women Diagnosed With Estrogen Receptor-Positive Invasive Breast Cancer [My Copy] J Clin Oncol (8 September 2009), JCO.2009.23.1597. by Christopher I. Li, Janet R. Daling, Peggy L. Porter, Mei-Tzu C. Tang, Kathleen E. Malone posted to smoking second primary obesity contralateral cancer breast alcohol by songpku on 2009-10-28 19:00:56 as along with 1 person aeisen
	Genetic polymorphisms of CYP2D6 10 and CYP2C19 2, 3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen. [My Copy] Cancer, Vol. 115, No. 5. (1 March 2009), pp. 952-961. by Masatsugu Okishiro, Tetsuya Taguchi, Seung Jin Kim, Kenzo Shimazu, Yasuhiro Tamaki, Shinzaburo Noguchi posted to tamoxifen pharmacogenetics cyp2d6 breast asian_populations by misonneh on 2009-10-27 07:17:16 as along with 2 people ilsun Mi-Seon
	Impact of CYP2D610 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy. [My Copy] Cancer science*, Vol. 99, No. 5. (May 2008), pp. 995-999. by Kazuma Kiyotani, Taisei Mushiroda, Mitsunori Sasa, et al.Yoshimi Bando, Ikuko Sumitomo, Naoya Hosono, Michiaki Kubo, Yusuke Nakamura, Hitoshi Zembutsu posted to pharmacogenetics cyp2d6 breast asian_populations by misonneh on 2009-10-27 07:12:50 as
	Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. [My Copy] Journal of the National Cancer Institute, Vol. 95, No. 23. (3 December 2003), pp. 1758-1764. by Vered Stearns, Michael D. Johnson, James M. Rae, et al.Alan Morocho, Antonella Novielli, Pankaj Bhargava, Daniel F. Hayes, Zeruesenay Desta, David A. Flockhart posted to tamoxifen pk pharmacogenetics metabolism ddi breast by misonneh on 2009-10-27 07:02:30 as
	CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. [My Copy] Journal of the National Cancer Institute, Vol. 97, No. 1. (5 January 2005), pp. 30-39. by Yan Jin, Zeruesenay Desta, Vered Stearns, et al.Bryan Ward, Herbert Ho, Kyung-Hoon H. Lee, Todd Skaar, Anna Maria M. Storniolo, Lang Li, Adjei Araba, Rebecca Blanchard, Anne Nguyen, Lynda Ullmer, Jill Hayden, Suzanne Lemler, Richard M. Weinshilboum, James M. Rae, Daniel F. Hayes, David A. Flockhart posted to tamoxifen pharmacogenetics genetics ddi cyp2d6 breast by misonneh on 2009-10-27 07:01:49 as along with 1 person frohike
	Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment. [My Copy] Clinical pharmacology and therapeutics, Vol. 80, No. 1. (July 2006), pp. 61-74. by Silvana Borges, Zeruesenay Desta, Lang Li, et al.Todd C. Skaar, Bryan A. Ward, Anne Nguyen, Yan Jin, Anna Maria M. Storniolo, D. Michele Nikoloff, Lin Wu, Grant Hillman, Daniel F. Hayes, Vered Stearns, David A. Flockhart posted to tamoxifen pk pharmacogenetics metabolism cyp2d6 breast by misonneh on 2009-10-27 07:01:06 as
	Germline pharmacogenetics of tamoxifen response: have we learned enough? [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 25, No. 33. (20 November 2007), pp. 5147-5149. by Zeruesenay Desta, David A. Flockhart posted to tamoxifen pharmacogenetics genetics cyp2d6 comments breast by misonneh on 2009-10-27 06:59:30 as
	Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen. [My Copy] JAMA : the journal of the American Medical Association, Vol. 302, No. 13. (7 October 2009), pp. 1429-1436. by Werner Schroth, Matthew P. Goetz, Ute Hamann, et al.Peter A. Fasching, Marcus Schmidt, Stefan Winter, Peter Fritz, Wolfgang Simon, Vera J. Suman, Matthew M. Ames, Stephanie L. Safgren, Mary J. Kuffel, Hans Ulrich U. Ulmer, Julia Boländer, Reiner Strick, Matthias W. Beckmann, Heinz Koelbl, Richard M. Weinshilboum, James N. Ingle, Michel Eichelbaum, Matthias Schwab, Hiltrud Brauch posted to tamoxifen prognosis prediction pharmacogenetics genotype cyp2d6 breast by misonneh on 2009-10-26 06:36:40 as along with 1 person merpublic
	Genome wide transcriptional profiling in breast cancer cells reveals distinct changes in hormone receptor target genes and chromatin modifying enzymes after proteasome inhibition [My Copy] Molecular Carcinogenesis, Vol. 47, No. 11. (2008), pp. 845-885. by H. Karimi Kinyamu, Jennifer B. Collins, Sherry F. Grissom, Pratibha B. Hebbar, Trevor K. Archer posted to gr expression_profiles era er_target er breast_cancer breast by tonamswish on 2009-10-24 18:11:24 as
	Intratumoral Cytokines and Tumor Cell Biology Determine Spontaneous Breast Cancer-Specific Immune Responses and Their Correlation to Prognosis. [My Copy] Cancer research (20 October 2009) by Christoph Domschke, Florian Schuetz, Yingzi Ge, et al.Tobias Seibel, Christine Falk, Benedikt Brors, Israel Vlodavsky, Nora Sommerfeldt, Hans-Peter P. Sinn, Marie-Christine C. Kühnle, Andreas Schneeweiss, Alexander Scharf, Christof Sohn, Volker Schirrmacher, Gerhard Moldenhauer, Frank Momburg, Philipp Beckhove posted to prognosis immune-response cytokine cancer breast by Zephyrus on 2009-10-22 13:26:19 as
	Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery [My Copy] PLoS ONE, Vol. 4, No. 7. (3 July 2009), e6146. by Jessica Kao, Keyan Salari, Melanie Bocanegra, et al.Yoon-La Choi, Luc Girard, Jeet Gandhi, Kevin A. Kwei, Tina Hernandez-Boussard, Pei Wang, Adi F. Gazdar, John D. Minna, Jonathan R. Pollack posted to expression_profiles era er breast_cancer breast by tonamswish on 2009-10-22 03:09:46 as along with 2 people eshirdel chrisamiller
	Widespread Estrogen-Dependent Repression of microRNAs Involved in Breast Tumor Cell Growth. [My Copy] Cancer research (13 October 2009) by Gérard Maillot, Magali Lacroix-Triki, Sandra Pierredon, et al.Lise Gratadou, Sabine Schmidt, Vladimir Bénès, Henri Roché, Florence Dalenc, Didier Auboeuf, Stefania Millevoi, Stéphan Vagner posted to mirna interesting estrogen cancer breast by Zephyrus on 2009-10-21 22:30:20 as along with 2 people and 2 groups tonamswish omkara microRNA Breast Cancer Reading Club
	Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy. [My Copy] Breast cancer research and treatment, Vol. 115, No. 3. (June 2009), pp. 643-650. by Adedayo A. Onitilo, Catherine A. McCarty, Russell A. Wilke, et al.Ingrid Glurich, Jessica M. Engel, David A. Flockhart, Anne Nguyen, Lang Li, Deming Mi, Todd C. Skaar, Yan Jin posted to tamoxifen pharmacogenetics hr genetics breast adr by misonneh on 2009-10-21 02:21:36 as
	Multiparity and the risk of premenopausal breast cancer: different effects across ethnic groups in Singapore. [My Copy] Breast cancer research and treatment, Vol. 113, No. 3. (February 2009), pp. 553-558. by Helena M. Verkooijen, Karen P. Yap, Vineta Bhalla, Khuan Yew Y. Chow, Kee Seng S. Chia posted to risk_factor race parity hormone estrogen epidemiology breast by misonneh on 2009-10-21 01:30:03 as
	Do Asian breast cancer patients have poorer survival than their western counterparts? A comparison between Singapore and Stockholm. [My Copy] Breast cancer research : BCR, Vol. 11, No. 1. (24 January 2009), R4. by Benita Kiat Tee K. Tan, Gek Hsiang H. Lim, Kamila Czene, Per Hall, Kee Seng S. Chia posted to trend survival prognosis epidemiology breast asian_populations by misonneh on 2009-10-21 01:27:20 as
	Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients [My Copy] Breast Cancer Research and Treatment, Vol. 91, No. 3. (28 June 2005), pp. 249-258. by Susan A. Nowell, Jiyoung Ahn, James M. Rae, et al.Joshua O. Scheys, Andrew Trovato, Carol Sweeney, Stewart L. MacLeod, Fred F. Kadlubar, Christine B. Ambrosone posted to tamoxifen pharmacogenetics cyp2d6 cancer breast by songpku on 2009-10-19 21:58:35 as along with 2 people Mi-Seon frohike
	CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer. [My Copy] Breast cancer research : BCR, Vol. 9, No. 6. (17 December 2007), R87. by Francisco J. Esteva, Jing Wang, Feng Lin, et al.Jaime A. Mejia, Kai Yan, Kadri Altundag, Vicente Valero, Aman U. Buzdar, Gabriel N. Hortobagyi, W. Fraser Symmans, Lajos Pusztai posted to response prediction neoadjuvant immunity her2 breast biomarker by misonneh on 2009-10-19 08:49:42 as
	Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 3. (6 February 2008), pp. 207-212. by Giuseppe Viale, Meredith M. Regan, Mauro G. Mastropasqua, et al.Fausto Maffini, Eugenio Maiorano, Marco Colleoni, Karen N. Price, Rastko Golouh, Tiziana Perin, R. W. Brown, Anikó Kovács, Komala Pillay, Christian Ohlschlegel, Barry A. Gusterson, Monica Castiglione-Gertsch, Richard D. Gelber, Aron Goldhirsch, Alan S. Coates, International Breast Cancer Study Group posted to prognosis prediction ki67 hormone chemotherapy breast biomarker by misonneh on 2009-10-19 08:47:32 as
	Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 8. (10 March 2008), pp. 1275-1281. by Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess, et al.Fabrice André, Attila Tordai, Jaime A. Mejia, W. Fraser Symmans, Ana M. Gonzalez-Angulo, Bryan Hennessy, Marjorie Green, Massimo Cristofanilli, Gabriel N. Hortobagyi, Lajos Pusztai posted to survival prognosis prediction neoadjuvant chemotherapy breast biomarker by misonneh on 2009-10-19 08:44:43 as
	Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance. [My Copy] Breast cancer research and treatment, Vol. 112, No. 3. (9 December 2008), pp. 475-488. by Djuana M. Harvell, Nicole S. Spoelstra, Meenakshi Singh, et al.James L. McManaman, Christina Finlayson, Tzu Phang, Susan Trapp, Lawrence Hunter, Wendy W. Dye, Virginia F. Borges, Anthony Elias, Kathryn B. Horwitz, Jennifer K. Richer posted to resonse resistance neoadjuvant hormone chemotherapy breast biomarker by misonneh on 2009-10-19 08:44:01 as along with 1 person jfr
	Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast. [My Copy] Breast cancer research : BCR, Vol. 10, No. 2. (01 April 2008), R30. by Gunter von Minckwitz, Hans-Peter P. Sinn, Günter Raab, et al.Sibylle Loibl, Jens-Uwe U. Blohmer, Holger Eidtmann, Jörn Hilfrich, Elisabeth Merkle, Christian Jackisch, Serban D. Costa, Angelika Caputo, Manfred Kaufmann, German Breast Group posted to response neoadjuvant dynamic chemotherapy breast biomarker by misonneh on 2009-10-19 08:42:21 as
	The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer. [My Copy] Breast cancer research and treatment, Vol. 116, No. 1. (1 July 2009), pp. 53-68. by Robin L. Jones, Janine Salter, Roger A'Hern, et al.Ash Nerurkar, Marina Parton, Jorge S. Reis-Filho, Ian E. Smith, Mitchell Dowsett posted to prediction neoadjuvant dynamic chemotherapy breast biomarker by misonneh on 2009-10-19 08:39:43 as along with 1 person Zephyrus
	Changes in tumour biological markers during primary systemic chemotherapy (PST). [My Copy] Anticancer research, Vol. 28, No. 3B. (n 2008), pp. 1797-1804. by Hans Neubauer, Christian Gall, Ulrich Vogel, et al.Rene Hornung, Diethelm Wallwiener, Erich Solomayer, Tanja Fehm posted to response dynamic chemotherapy breast biomarker by misonneh on 2009-10-19 08:37:21 as
	Tumor-infiltrating lymphocytes predict response to neoadjuvant chemotherapy in patients with breast carcinoma. [My Copy] Cancer investigation, Vol. 26, No. 10. (December 2008), pp. 1024-1031. by Helena Hornychova, Bohuslav Melichar, Marketa Tomsova, Jindøiska Mergancova, Hana Urminska, Ales Ryska posted to response neoadjuvant immunity chemotherapy breast biomarker by misonneh on 2009-10-19 08:17:43 as

Note: You may cite this page as: http://www.citeulike.org/tag/breast

Result page: 1 2 3 4 5 6 7 8 9 10 Next

cancer	2510
thelist	1379
superlist	444
review	286
aggressiveness	214
estrogen	212
prognosis	187
background	148
metastasis	138
survival	108
receptor	101
therapy	101
hormone	99
tamoxifen	99
genetics	87
grade	81
estrogen-receptor	80
aggressiveness-prediction	78
gene-expression	76
basal	73
risk	71
signature	70
her2	64
molecular	64
expression	63
dod	62
epigenetics	61
justification	59
prediction	59
resistance	59
microarray	58
check	57
chemotherapy	56
dcis	56
pharmacogenetics	56
epidemiology	54
genetic	54
biomarker	53
progression	50
heterogeneity	49
list	49
methylation	49
african-american	48
tumour	46
age	45
evolution	45
diagnosis	44
microrna	43
response	43
xenoestrogen	42
cancer-crosstalk	41
markers	41
pathway	41
apoptosis	40
hrt	40
methods	40
pathology	40
mri	39
subtypes	38
gene	36
read	36
brca	34
immune	34
pregnancy	34
prevention	34
d	33
disparity	33
mammography	33
triple-negative	33
vitamin	33
classification	32
disparities	32
immunology	32
negative	32
polymorphism	32
racial	32
africa	31
herceptin	31
obesity	31
peripheral	31
stress	31
gwas	30
measurement	30
progesterone	30
cell	29
tumor	29
biology	28
dce-mri	28
involution	28
diet	27
aromatase	25
cyp2d6	25
er	25
gene_specific_methylation	25
neoadjuvant	25
thesis	25
adipose	24
mcf-7	24
model	24
tissue	24

Tag breast [more than 800 articles] Export

Related Tags